loading page

Novel Reaction to New Cystic Fibrosis Medication Trikafta
  • Julian Stashower,
  • Patrick Carr,
  • Barrett Zlotoff
Julian Stashower
University of Virginia School of Medicine
Author Profile
Patrick Carr
University of Virginia School of Medicine
Author Profile
Barrett Zlotoff
University of Virginia School of Medicine
Author Profile

Abstract

We present a novel case of an urticaria multiforme-type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.

Peer review status:UNDER REVIEW

06 Aug 2020Submitted to Clinical Case Reports
08 Aug 2020Assigned to Editor
08 Aug 2020Submission Checks Completed
21 Aug 2020Reviewer(s) Assigned
19 Oct 2020Review(s) Completed, Editorial Evaluation Pending